Nielsen Kirk G.
SEC insider (Form 3/4/5 filer). CIK 0001523522. Director at CVRx, Inc. (CVRX) and 1 other issuer. 16 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in MINNEAPOLIS, MN.
Companies Nielsen Kirk G. has filed insider reports for
- CVRx, Inc. (CVRX): Director
- SpyGlass Pharma, Inc. (SGP): Director, 10% Owner
Nielsen Kirk G.
CIK: 0001523522
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 1, 2026CVRX
CVRx, Inc.
AwardDirect8.7K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirectSeries D Preferred Stock
359.3K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirectSeries C-2 Preferred Stock
548.1K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirectSeries C-1 Preferred Stock
548.1K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirectSeries B Preferred Stock
1.7M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
PurchaseIndirect165K shares at avg. $16.00$2.6M - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect1.7M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect548.1K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect548.1K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect359.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2026 |  CVRX CVRx, Inc. | Award | 8,720 | - | $0 | Direct |
| Feb 9, 2026 |  SGP SpyGlass Pharma, Inc. | Conversion Series D Preferred Stock | 359,255 | - | - | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion Series C-2 Preferred Stock | 548,067 | - | - | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion Series C-1 Preferred Stock | 548,067 | - | - | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion Series B Preferred Stock | 1,690,230 | - | - | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Purchase | 165,000 | $16.00 | $2,640,000 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 1,690,230 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 548,067 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 548,067 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 359,255 | - | $0 | Indirect |
1-10 of 16 transactions